Absorbable Fibrin Sealant Patch Market By Application (General Surgery , Cardiovascular Surgery , Wound Management , Orthopedic Surgery , Urological Surgery, Ophthalmic Surgery, Others) , By End User (Hospitals and Clinics , Ambulatory Surgical Centers

Published Jul 01, 2024

Length 228 Pages

SKU # ALMR19230001

Description

Absorbable Fibrin Sealant Patch Market By Application (General Surgery , Cardiovascular Surgery , Wound Management , Orthopedic Surgery , Urological Surgery, Ophthalmic Surgery, Others) , By End User (Hospitals and Clinics , Ambulatory Surgical Centers , Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Absorbable Fibrin Sealant Patch Market
The absorbable fibrin sealant patch market was valued at $0.3 billion in 2023 and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
An absorbable fibrin sealant patch is a sterile object used in surgical procedures to control bleeding and promote tissue healing. It is a biodegradable patch comprising of equine collagen sponge along with fibrinogen and thrombin, elements which are the key players in the natural blood clotting mechanism of the body. The formulation of the patch involves absorption by the body over time, hence eradicating the need for removal and reducing the risk of infections. The sealant patch is significantly administered during surgeries in which conventional stapling or suturing is difficult or insufficient for hemostasis.
Rise in the conduction of surgical procedures across the globe due to increase in prevalence of cardiovascular, orthopedic, and general health complications is a key driver of the absorbable fibrin sealant patch market. Moreover, surge in the popularity of minimally invasive operations is boosting the adoption of sealant patches as they eliminate the post-recovery intricacies. As an emerging trend, sealant patches that are equally active and effective on both sides are acquiring traction. When compared to the conventional patches, the new sealant patches are reported to be quick by an average of six times, ceasing bleeding in 30 minutes.
However, the cost of surgical procedures involving the use of sealant patches is significantly high as compared to the traditional surgeries, which deters several individuals from preferring them. This acts a major restraint for the absorbable fibrin sealant patch market. On the contrary, constant advancements in sealant patches are expected to present lucrative opportunities for market expansion. According to a study published in Nature, a British scientific journal, next generation of patches are being designed that are projected to provide instant adhesion, possess compatibility with rapid photo-projection, and have the potential to deliver therapeutics.

Segment Review

The absorbable fibrin sealant patch market is segmented into application, end user, and region. On the basis of application, the market is divided into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, and others. As per end user, it is classified into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of application, the others segment dominates the absorbable fibrin sealant patch market.
As per end user, the hospitals & clinics segment holds a high share of the market.
Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global absorbable fibrin sealant patch market include Johnson & Johnson, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Key Market Segments

By Application

General Surgery
Cardiovascular Surgery
Wound Management
Orthopedic Surgery
Urological Surgery
Ophthalmic Surgery
Others

By End User

Hospitals and Clinics
Ambulatory Surgical Centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Johnson & Johnson
Baxter International Inc
Takeda Pharmaceutical Company Limited
Becton, Dickinson and Company.
Corza Medical
LifeBond Ltd
Surgical Specialties Corporation
Biegler GmbH
Cohera Medical Inc
Integra LifeSciences Corporation

CHAPTER 1: INTRODUCTION: 1.1. Report Description; 1.2. Key Market Segments; 1.3. Key Benefits; 1.4. Research Methodology; 1.4.1. Primary Research; 1.4.2. Secondary Research; 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY: 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE: 3.1. Market Definition and Scope; 3.2. Key Findings; 3.2.1. Top Investment Pockets; 3.2.2. Top Winning Strategies; 3.3. Porter's Five Forces Analysis; 3.3.1. Bargaining Power of Suppliers; 3.3.2. Threat of New Entrants; 3.3.3. Threat of Substitutes; 3.3.4. Competitive Rivalry; 3.3.5. Bargaining Power among Buyers; 3.4. Market Dynamics; 3.4.1. Drivers; 3.4.2. Restraints; 3.4.3. Opportunities
CHAPTER 4: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION: 4.1. Market Overview; 4.1.1 Market Size and Forecast, By Application; 4.2. General Surgery; 4.2.1. Key Market Trends, Growth Factors and Opportunities; 4.2.2. Market Size and Forecast, By Region; 4.2.3. Market Share Analysis, By Country; 4.3. Cardiovascular Surgery; 4.3.1. Key Market Trends, Growth Factors and Opportunities; 4.3.2. Market Size and Forecast, By Region; 4.3.3. Market Share Analysis, By Country; 4.4. Wound Management; 4.4.1. Key Market Trends, Growth Factors and Opportunities; 4.4.2. Market Size and Forecast, By Region; 4.4.3. Market Share Analysis, By Country; 4.5. Orthopedic Surgery; 4.5.1. Key Market Trends, Growth Factors and Opportunities; 4.5.2. Market Size and Forecast, By Region; 4.5.3. Market Share Analysis, By Country; 4.6. Urological Surgery; 4.6.1. Key Market Trends, Growth Factors and Opportunities; 4.6.2. Market Size and Forecast, By Region; 4.6.3. Market Share Analysis, By Country; 4.7. Ophthalmic Surgery; 4.7.1. Key Market Trends, Growth Factors and Opportunities; 4.7.2. Market Size and Forecast, By Region; 4.7.3. Market Share Analysis, By Country; 4.8. Others; 4.8.1. Key Market Trends, Growth Factors and Opportunities; 4.8.2. Market Size and Forecast, By Region; 4.8.3. Market Share Analysis, By Country
CHAPTER 5: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER: 5.1. Market Overview; 5.1.1 Market Size and Forecast, By End User; 5.2. Hospitals And Clinics; 5.2.1. Key Market Trends, Growth Factors and Opportunities; 5.2.2. Market Size and Forecast, By Region; 5.2.3. Market Share Analysis, By Country; 5.3. Ambulatory Surgical Centers; 5.3.1. Key Market Trends, Growth Factors and Opportunities; 5.3.2. Market Size and Forecast, By Region; 5.3.3. Market Share Analysis, By Country; 5.4. Others; 5.4.1. Key Market Trends, Growth Factors and Opportunities; 5.4.2. Market Size and Forecast, By Region; 5.4.3. Market Share Analysis, By Country
CHAPTER 6: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION: 6.1. Market Overview; 6.1.1 Market Size and Forecast, By Region; 6.2. North America; 6.2.1. Key Market Trends and Opportunities; 6.2.2. Market Size and Forecast, By Application; 6.2.3. Market Size and Forecast, By End User; 6.2.4. Market Size and Forecast, By Country; 6.2.5. U.S. Absorbable Fibrin Sealant Patch Market; 6.2.5.1. Market Size and Forecast, By Application; 6.2.5.2. Market Size and Forecast, By End User; 6.2.6. Canada Absorbable Fibrin Sealant Patch Market; 6.2.6.1. Market Size and Forecast, By Application; 6.2.6.2. Market Size and Forecast, By End User; 6.2.7. Mexico Absorbable Fibrin Sealant Patch Market; 6.2.7.1. Market Size and Forecast, By Application; 6.2.7.2. Market Size and Forecast, By End User; 6.3. Europe; 6.3.1. Key Market Trends and Opportunities; 6.3.2. Market Size and Forecast, By Application; 6.3.3. Market Size and Forecast, By End User; 6.3.4. Market Size and Forecast, By Country; 6.3.5. Germany Absorbable Fibrin Sealant Patch Market; 6.3.5.1. Market Size and Forecast, By Application; 6.3.5.2. Market Size and Forecast, By End User; 6.3.6. France Absorbable Fibrin Sealant Patch Market; 6.3.6.1. Market Size and Forecast, By Application; 6.3.6.2. Market Size and Forecast, By End User; 6.3.7. UK Absorbable Fibrin Sealant Patch Market; 6.3.7.1. Market Size and Forecast, By Application; 6.3.7.2. Market Size and Forecast, By End User; 6.3.8. Italy Absorbable Fibrin Sealant Patch Market; 6.3.8.1. Market Size and Forecast, By Application; 6.3.8.2. Market Size and Forecast, By End User; 6.3.9. Spain Absorbable Fibrin Sealant Patch Market; 6.3.9.1. Market Size and Forecast, By Application; 6.3.9.2. Market Size and Forecast, By End User; 6.3.10. Rest Of Europe Absorbable Fibrin Sealant Patch Market; 6.3.10.1. Market Size and Forecast, By Application; 6.3.10.2. Market Size and Forecast, By End User; 6.4. Asia-Pacific; 6.4.1. Key Market Trends and Opportunities; 6.4.2. Market Size and Forecast, By Application; 6.4.3. Market Size and Forecast, By End User; 6.4.4. Market Size and Forecast, By Country; 6.4.5. Japan Absorbable Fibrin Sealant Patch Market; 6.4.5.1. Market Size and Forecast, By Application; 6.4.5.2. Market Size and Forecast, By End User; 6.4.6. China Absorbable Fibrin Sealant Patch Market; 6.4.6.1. Market Size and Forecast, By Application; 6.4.6.2. Market Size and Forecast, By End User; 6.4.7. India Absorbable Fibrin Sealant Patch Market; 6.4.7.1. Market Size and Forecast, By Application; 6.4.7.2. Market Size and Forecast, By End User; 6.4.8. Australia Absorbable Fibrin Sealant Patch Market; 6.4.8.1. Market Size and Forecast, By Application; 6.4.8.2. Market Size and Forecast, By End User; 6.4.9. South Korea Absorbable Fibrin Sealant Patch Market; 6.4.9.1. Market Size and Forecast, By Application; 6.4.9.2. Market Size and Forecast, By End User; 6.4.10. Rest of Asia-Pacific Absorbable Fibrin Sealant Patch Market; 6.4.10.1. Market Size and Forecast, By Application; 6.4.10.2. Market Size and Forecast, By End User; 6.5. LAMEA; 6.5.1. Key Market Trends and Opportunities; 6.5.2. Market Size and Forecast, By Application; 6.5.3. Market Size and Forecast, By End User; 6.5.4. Market Size and Forecast, By Country; 6.5.5. Brazil Absorbable Fibrin Sealant Patch Market; 6.5.5.1. Market Size and Forecast, By Application; 6.5.5.2. Market Size and Forecast, By End User; 6.5.6. Saudi Arabia Absorbable Fibrin Sealant Patch Market; 6.5.6.1. Market Size and Forecast, By Application; 6.5.6.2. Market Size and Forecast, By End User; 6.5.7. South Africa Absorbable Fibrin Sealant Patch Market; 6.5.7.1. Market Size and Forecast, By Application; 6.5.7.2. Market Size and Forecast, By End User; 6.5.8. Rest of LAMEA Absorbable Fibrin Sealant Patch Market; 6.5.8.1. Market Size and Forecast, By Application; 6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE: 7.1. Introduction; 7.2. Top Winning Strategies; 7.3. Product Mapping Of Top 10 Player; 7.4. Competitive Dashboard; 7.5. Competitive Heatmap; 7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES: 8.1. Johnson And Johnson; 8.1.1. Company Overview; 8.1.2. Key Executives; 8.1.3. Company Snapshot; 8.1.4. Operating Business Segments; 8.1.5. Product Portfolio; 8.1.6. Business Performance; 8.1.7. Key Strategic Moves and Developments; 8.2. Baxter International Inc; 8.2.1. Company Overview; 8.2.2. Key Executives; 8.2.3. Company Snapshot; 8.2.4. Operating Business Segments; 8.2.5. Product Portfolio; 8.2.6. Business Performance; 8.2.7. Key Strategic Moves and Developments; 8.3. Takeda Pharmaceutical Company Limited; 8.3.1. Company Overview; 8.3.2. Key Executives; 8.3.3. Company Snapshot; 8.3.4. Operating Business Segments; 8.3.5. Product Portfolio; 8.3.6. Business Performance; 8.3.7. Key Strategic Moves and Developments; 8.4. Becton, Dickinson And Company.; 8.4.1. Company Overview; 8.4.2. Key Executives; 8.4.3. Company Snapshot; 8.4.4. Operating Business Segments; 8.4.5. Product Portfolio; 8.4.6. Business Performance; 8.4.7. Key Strategic Moves and Developments; 8.5. Corza Medical; 8.5.1. Company Overview; 8.5.2. Key Executives; 8.5.3. Company Snapshot; 8.5.4. Operating Business Segments; 8.5.5. Product Portfolio; 8.5.6. Business Performance; 8.5.7. Key Strategic Moves and Developments; 8.6. LifeBond Ltd; 8.6.1. Company Overview; 8.6.2. Key Executives; 8.6.3. Company Snapshot; 8.6.4. Operating Business Segments; 8.6.5. Product Portfolio; 8.6.6. Business Performance; 8.6.7. Key Strategic Moves and Developments; 8.7. Surgical Specialties Corporation; 8.7.1. Company Overview; 8.7.2. Key Executives; 8.7.3. Company Snapshot; 8.7.4. Operating Business Segments; 8.7.5. Product Portfolio; 8.7.6. Business Performance; 8.7.7. Key Strategic Moves and Developments; 8.8. Biegler GmbH; 8.8.1. Company Overview; 8.8.2. Key Executives; 8.8.3. Company Snapshot; 8.8.4. Operating Business Segments; 8.8.5. Product Portfolio; 8.8.6. Business Performance; 8.8.7. Key Strategic Moves and Developments; 8.9. Cohera Medical Inc; 8.9.1. Company Overview; 8.9.2. Key Executives; 8.9.3. Company Snapshot; 8.9.4. Operating Business Segments; 8.9.5. Product Portfolio; 8.9.6. Business Performance; 8.9.7. Key Strategic Moves and Developments; 8.10. Integra LifeSciences Corporation; 8.10.1. Company Overview; 8.10.2. Key Executives; 8.10.3. Company Snapshot; 8.10.4. Operating Business Segments; 8.10.5. Product Portfolio; 8.10.6. Business Performance; 8.10.7. Key Strategic Moves and Developments; TABLE 1. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 2. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR GENERAL SURGERY , BY REGION, 2024 - 2033 ($BILLION); TABLE 3. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR CARDIOVASCULAR SURGERY , BY REGION, 2024 - 2033 ($BILLION); TABLE 4. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR WOUND MANAGEMENT , BY REGION, 2024 - 2033 ($BILLION); TABLE 5. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR ORTHOPEDIC SURGERY , BY REGION, 2024 - 2033 ($BILLION); TABLE 6. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR UROLOGICAL SURGERY, BY REGION, 2024 - 2033 ($BILLION); TABLE 7. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OPHTHALMIC SURGERY, BY REGION, 2024 - 2033 ($BILLION); TABLE 8. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION); TABLE 9. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 10. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR HOSPITALS AND CLINICS , BY REGION, 2024 - 2033 ($BILLION); TABLE 11. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR AMBULATORY SURGICAL CENTERS , BY REGION, 2024 - 2033 ($BILLION); TABLE 12. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION); TABLE 13. ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION, 2024 - 2033 ($BILLION); TABLE 14. NORTH AMERICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 15. NORTH AMERICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 16. NORTH AMERICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 17. U.S. ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 18. U.S. ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 19. CANADA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 20. CANADA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 21. MEXICO ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 22. MEXICO ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 23. EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 24. EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 25. EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 26. GERMANY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 27. GERMANY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 28. FRANCE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 29. FRANCE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 30. UK ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 31. UK ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 32. ITALY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 33. ITALY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 34. SPAIN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 35. SPAIN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 36. REST OF EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 37. REST OF EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 38. ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 39. ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 40. ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 41. JAPAN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 42. JAPAN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 43. CHINA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 44. CHINA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 45. INDIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 46. INDIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 47. AUSTRALIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 48. AUSTRALIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 49. SOUTH KOREA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 50. SOUTH KOREA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 51. REST OF ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 52. REST OF ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 53. LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 54. LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 55. LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 56. BRAZIL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 57. BRAZIL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 58. SAUDI ARABIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 59. SAUDI ARABIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 60. SOUTH AFRICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 61. SOUTH AFRICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 62. REST OF LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION , 2024 - 2033 ($BILLION); TABLE 63. REST OF LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 64. JOHNSON AND JOHNSON: KEY EXECUTIVES; TABLE 65. JOHNSON AND JOHNSON: COMPANY SNAPSHOT; TABLE 66. JOHNSON AND JOHNSON: OPERATING SEGMENTS; TABLE 67. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO; TABLE 68. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 69. BAXTER INTERNATIONAL INC : KEY EXECUTIVES; TABLE 70. BAXTER INTERNATIONAL INC : COMPANY SNAPSHOT; TABLE 71. BAXTER INTERNATIONAL INC : OPERATING SEGMENTS; TABLE 72. BAXTER INTERNATIONAL INC : PRODUCT PORTFOLIO; TABLE 73. BAXTER INTERNATIONAL INC : KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 74. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY EXECUTIVES; TABLE 75. TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT; TABLE 76. TAKEDA PHARMACEUTICAL COMPANY LIMITED: OPERATING SEGMENTS; TABLE 77. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT PORTFOLIO; TABLE 78. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 79. BECTON, DICKINSON AND COMPANY. : KEY EXECUTIVES; TABLE 80. BECTON, DICKINSON AND COMPANY. : COMPANY SNAPSHOT; TABLE 81. BECTON, DICKINSON AND COMPANY. : OPERATING SEGMENTS; TABLE 82. BECTON, DICKINSON AND COMPANY. : PRODUCT PORTFOLIO; TABLE 83. BECTON, DICKINSON AND COMPANY. : KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 84. CORZA MEDICAL: KEY EXECUTIVES; TABLE 85. CORZA MEDICAL: COMPANY SNAPSHOT; TABLE 86. CORZA MEDICAL: OPERATING SEGMENTS; TABLE 87. CORZA MEDICAL: PRODUCT PORTFOLIO; TABLE 88. CORZA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 89. LIFEBOND LTD : KEY EXECUTIVES; TABLE 90. LIFEBOND LTD : COMPANY SNAPSHOT; TABLE 91. LIFEBOND LTD : OPERATING SEGMENTS; TABLE 92. LIFEBOND LTD : PRODUCT PORTFOLIO; TABLE 93. LIFEBOND LTD : KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 94. SURGICAL SPECIALTIES CORPORATION : KEY EXECUTIVES; TABLE 95. SURGICAL SPECIALTIES CORPORATION : COMPANY SNAPSHOT; TABLE 96. SURGICAL SPECIALTIES CORPORATION : OPERATING SEGMENTS; TABLE 97. SURGICAL SPECIALTIES CORPORATION : PRODUCT PORTFOLIO; TABLE 98. SURGICAL SPECIALTIES CORPORATION : KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 99. BIEGLER GMBH : KEY EXECUTIVES; TABLE 100. BIEGLER GMBH : COMPANY SNAPSHOT; TABLE 101. BIEGLER GMBH : OPERATING SEGMENTS; TABLE 102. BIEGLER GMBH : PRODUCT PORTFOLIO; TABLE 103. BIEGLER GMBH : KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 104. COHERA MEDICAL INC : KEY EXECUTIVES; TABLE 105. COHERA MEDICAL INC : COMPANY SNAPSHOT; TABLE 106. COHERA MEDICAL INC : OPERATING SEGMENTS; TABLE 107. COHERA MEDICAL INC : PRODUCT PORTFOLIO; TABLE 108. COHERA MEDICAL INC : KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 109. INTEGRA LIFESCIENCES CORPORATION: KEY EXECUTIVES; TABLE 110. INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT; TABLE 111. INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS; TABLE 112. INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO; TABLE 113. INTEGRA LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS; FIGURE 1. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET, 2024 - 2033; FIGURE 2. SEGMENTATION OF ABSORBABLE FIBRIN SEALANT PATCH MARKET, 2024 - 2033; FIGURE 3. TOP INVESTMENT POCKET IN ABSORBABLE FIBRIN SEALANT PATCH MARKET; FIGURE 4. MODERATE BARGAINING POWER OF BUYERS; FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS; FIGURE 6. MODERATE THREAT OF NEW ENTRANTS; FIGURE 7. LOW THREAT OF SUBSTITUTION; FIGURE 8. HIGH COMPETITIVE RIVALRY; FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALABSORBABLE FIBRIN SEALANT PATCH MARKET; FIGURE 10. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET SEGMENTATION, BY APPLICATION; FIGURE 11. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR GENERAL SURGERY , BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 12. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR CARDIOVASCULAR SURGERY , BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 13. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR WOUND MANAGEMENT , BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 14. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR ORTHOPEDIC SURGERY , BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 15. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 16. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OPHTHALMIC SURGERY, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 17. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 18. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET SEGMENTATION, BY END USER; FIGURE 19. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR HOSPITALS AND CLINICS , BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 20. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR AMBULATORY SURGICAL CENTERS , BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 21. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*; FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*; FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*; FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS; FIGURE 26. COMPETITIVE DASHBOARD; FIGURE 27. COMPETITIVE HEATMAP: ABSORBABLE FIBRIN SEALANT PATCH MARKET; FIGURE 28. TOP PLAYER POSITIONING, 2023; FIGURE 29. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION); FIGURE 30. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 31. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 32. BAXTER INTERNATIONAL INC : NET SALES, 2021-2023 ($BILLION); FIGURE 33. BAXTER INTERNATIONAL INC : REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 34. BAXTER INTERNATIONAL INC : REVENUE SHARE, BY REGION, 2023 (%); FIGURE 35. TAKEDA PHARMACEUTICAL COMPANY LIMITED: NET SALES, 2021-2023 ($BILLION); FIGURE 36. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 37. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 38. BECTON, DICKINSON AND COMPANY. : NET SALES, 2021-2023 ($BILLION); FIGURE 39. BECTON, DICKINSON AND COMPANY. : REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 40. BECTON, DICKINSON AND COMPANY. : REVENUE SHARE, BY REGION, 2023 (%); FIGURE 41. CORZA MEDICAL: NET SALES, 2021-2023 ($BILLION); FIGURE 42. CORZA MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 43. CORZA MEDICAL: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 44. LIFEBOND LTD : NET SALES, 2021-2023 ($BILLION); FIGURE 45. LIFEBOND LTD : REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 46. LIFEBOND LTD : REVENUE SHARE, BY REGION, 2023 (%); FIGURE 47. SURGICAL SPECIALTIES CORPORATION : NET SALES, 2021-2023 ($BILLION); FIGURE 48. SURGICAL SPECIALTIES CORPORATION : REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 49. SURGICAL SPECIALTIES CORPORATION : REVENUE SHARE, BY REGION, 2023 (%); FIGURE 50. BIEGLER GMBH : NET SALES, 2021-2023 ($BILLION); FIGURE 51. BIEGLER GMBH : REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 52. BIEGLER GMBH : REVENUE SHARE, BY REGION, 2023 (%); FIGURE 53. COHERA MEDICAL INC : NET SALES, 2021-2023 ($BILLION); FIGURE 54. COHERA MEDICAL INC : REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 55. COHERA MEDICAL INC : REVENUE SHARE, BY REGION, 2023 (%); FIGURE 56. INTEGRA LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION); FIGURE 57. INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 58. INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)

Pricing

Currency Rates

Single User Email from Publisher $5,730
Global Site License Email from Publisher $7,412

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now